← Oncology Approval Tracker

FDA DECISION ·

Cabazitaxel Injection

cabazitaxel with prednisone · Accord Healthcare

FDA approvalNew formulationProstate cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Alternate intravenous cabazitaxel formulation, in combination with prednisone, for metastatic castration-resistant prostate cancer after a docetaxel-containing regimen.

LAMPGEN ANALYSIS

Why it matters

This 505(b)(2) approval adds a product that can be diluted for infusion without the separate predilution step used by the reference formulation.

What research teams should watch

Keep the formulation and dilution method explicit in pharmacy workflows and verify prior docetaxel exposure.

PRIMARY RECORDS

Sources